Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
2.070
-0.035 (-1.66%)
At close: Nov 6, 2026, 4:00 PM EST
2.100
+0.030 (1.45%)
After-hours: Nov 6, 2026, 7:41 PM EST
Niagen Bioscience Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 122.29 | 129.42 | 99.6 | 83.57 | 72.05 | 67.45 | |
Revenue Growth | -1.94% | 29.95% | 19.18% | 15.99% | 6.82% | 13.83% |
Cost of Revenue | 44.19 | 46.23 | 38.01 | 32.79 | 29.25 | 25.96 |
Gross Profit | 78.1 | 83.19 | 61.59 | 50.78 | 42.8 | 41.49 |
Selling, General & Admin | 68.81 | 62.56 | 47.84 | 51.42 | 56.6 | 64.73 |
Research & Development | 6.5 | 6.33 | 6.02 | 4.96 | 4.83 | 3.83 |
Operating Expenses | 75.31 | 68.89 | 53.86 | 56.38 | 61.43 | 68.56 |
Operating Income | 2.79 | 14.3 | 7.73 | -5.6 | -18.63 | -27.07 |
Interest Expense | - | - | - | - | - | -0.06 |
Interest & Investment Income | 1.71 | 2.13 | 1.13 | 0.66 | 0 | - |
Other Non Operating Income (Expenses) | -0.21 | -0.21 | - | - | - | - |
EBT Excluding Unusual Items | 4.29 | 16.21 | 8.86 | -4.94 | -18.63 | -27.13 |
Other Unusual Items | 1.98 | 1.98 | - | - | 2.09 | - |
Pretax Income | 11.06 | 18.19 | 8.86 | -4.94 | -16.54 | -27.13 |
Income Tax Expense | 0.82 | 0.81 | 0.31 | - | - | - |
Earnings From Continuing Operations | 10.24 | 17.38 | 8.55 | -4.94 | -16.54 | -27.13 |
Net Income | 10.24 | 17.38 | 8.55 | -4.94 | -16.54 | -27.13 |
Net Income to Common | 10.24 | 17.38 | 8.55 | -4.94 | -16.54 | -27.13 |
Net Income Growth | -49.88% | 103.30% | - | - | - | - |
Shares Outstanding (Basic) | 80 | 79 | 76 | 75 | 70 | 67 |
Shares Outstanding (Diluted) | 83 | 85 | 78 | 75 | 70 | 67 |
Shares Change | -1.42% | 9.36% | 4.19% | 7.54% | 3.79% | 10.02% |
EPS (Basic) | 0.13 | 0.22 | 0.11 | -0.07 | -0.24 | -0.40 |
EPS (Diluted) | 0.12 | 0.20 | 0.11 | -0.07 | -0.24 | -0.40 |
EPS Growth | -48.66% | 81.82% | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 4.58 | 13.21 | 11.95 | 6.97 | -15.43 | -24.57 |
Free Cash Flow Per Share | 0.06 | 0.15 | 0.15 | 0.09 | -0.22 | -0.37 |
Gross Margin | 63.86% | 64.28% | 61.83% | 60.76% | 59.40% | 61.51% |
Operating Margin | 2.28% | 11.05% | 7.76% | -6.70% | -25.85% | -40.14% |
Profit Margin | 8.37% | 13.43% | 8.58% | -5.91% | -22.96% | -40.22% |
Free Cash Flow Margin | 3.74% | 10.21% | 11.99% | 8.34% | -21.42% | -36.43% |
EBITDA | 3.86 | 15.08 | 8.54 | -4.57 | -17.57 | -25.96 |
EBITDA Margin | 3.16% | 11.65% | 8.58% | -5.47% | -24.39% | -38.48% |
D&A For EBITDA | 1.07 | 0.79 | 0.81 | 1.03 | 1.06 | 1.12 |
EBIT | 2.79 | 14.3 | 7.73 | -5.6 | -18.63 | -27.07 |
EBIT Margin | 2.28% | 11.05% | 7.76% | -6.70% | -25.85% | -40.14% |
Effective Tax Rate | 7.37% | 4.45% | 3.44% | - | - | - |
Advertising Expenses | - | 12.66 | 11.1 | 10.3 | 11.4 | 12.5 |